FDA Investigator Gerald D Bromley, Jr

Gerald D Bromley, Jr has conducted inspections on 113 sites in 6 countries as of 14 Dec 2011. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
113
Last Inspection Date:
14 Dec 2011
Investigator Role:
FDA Investigator
Redica ID:
100006326
Countries of Inspections:
United States of America, United Kingdom of Great Britain and Northern Ireland, Italy, Germany, Austria, Finland
FDA Investigators that have inspected at least one site in common with Gerald D Bromley, Jr:
Addie V Scott Boston, Adriana N Jimenez Lopez, Alan C Gion, Amanda Dinaro, Amos C Epps, Amy A Johnson, Amy C Amaro, Andrew J Howard, Andrew T Todd, Barbara A Crowl, Billingsley, Brandon L Mariner, Brett R Havranek, Brian R Yaun, Brigitte K Hofmann, Brigitte Kh Strelnik, Brooke K Higgins, Brooke K Seeman, Burnell M Henry, Candice C Mandera, Candice J Cortes, Carrie L Doupnik, Catherine J Laufmann, Charlean R Butler, Charles D Boison, Charles M Spyr, Charlotte E Wilkins, Cheryl G Scott, Christian D Lynch (CDL), Christina L Bigham, Christopher R Richardson, Clarice J Ahn, Cynthia A Harris, MD, RN, Daniel J Lahar, David L Chon, Dennis L Doupnik, Destry M Sillivan, Dianne H Milazzo, Dianne T Hamilton, Dina K West, Dirk L Lincoln, Dolores Harper, Douglas A Campbell, Edward A Brunt, Edward R Kay, Elena N Thomas, Emmanuel A Dimaano, Jr, Erin L Mcfiren, Esaw, Frank J Marciniak, George T Allen, Jr, Gerald Mierle, Gifford Whitehurst, Jr, Grace Deneke, Heath A Gerber, Heath W Cartwright, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James M Simpson, James W Leonette, Jamie D Richardson, Janice L King, Jeffrey J Thibodeau, Jesse A Vazquez, Joan A Loreng, Joey C West, John A Sciacchitano, John Dan, Johnny D Nwankwo, Johnson, Jose R Hernandez, Joseph George, Jude C Dikes, Justin A Boyd, Karen A Briggs, Karen S Anthony, Kenneth L Smalls, Kyle S Hobson, La Tasham Gunter, Laurie B Frazier, Lawrence Harmon, Jr, LCDR Anastasia M Piliafas Brown, LCDR Matthew J Morrison, LCDR Matthew R Mcnew, MPH, REHS/RS, LCDR Wilfred A Darang, Leo J Lagrotte, Linda J Eason, Linda K Weir, Linhart, Lisa L Gilliam, Lloyd M Luapula, Lori S Lawless, Luis A Dasta, Marc S Neubauer, Marcus A Ray, Margaret Torres Vazquez, Maribeth G Niesen, Marion Michaelis, Marion W Nadeau, Marla A Cassidy, Melinda L Rice, Melissa J Garcia, Michelle J Glembin, Nancy L Meade, Nathaniel R Esaw, Nelson N Ayangho, Nisha C Patel, Pelekakis, Perry H Gambrell, Peter E Gruman, Richard J Bashay, Ronald T Nowalk, Rose Ashley, Roy Baby, Sargum C Sood, Sean R Moynihan, MPH, Shannon A Gregory, Sherry L Secrist, BLT DO, Sierra M Shockley, Slatten, Stephanie L Shapley, Stephen C Eason, Steven J Thurber, Tamara N Champion, Tamika E Allen, RN, Tania E Vizcaino, Thai T Duong, Thomas J Hudson, Thuy T Nguyen, LCDR, Tiki J Dixon, Victoria A Wagoner, Walsworth, Weston K Szymanski, William D Bassett, Jr, William D Murray, William H Linkroum

Gerald D Bromley, Jr's Documents

Publish Date Document Type Title
September, 2001 EIR MicroAire Surgical Instruments, LLC - EIR, 2001-09-13
May, 2000 EIR PARI Respiratory Equipment, Inc. - EIR, 2000-05-03
October, 2003 EIR Bruker BioSpin MRI Gmbh - EIR, 2003-10-30
December, 2000 EIR Myer, Edwin C MD - EIR, 2000-12-13
January, 2000 FDA 483 Response Boehringer Ingelheim Chemicals, Inc. - Form 483R, 2000-02-07
March, 2003 FDA 483 Electronic Data Systems (eds) - Form 483, 2003-03-13
January, 2000 FDA 483 Boehringer Ingelheim Chemicals, Inc. - Form 483, 2000-01-07
February, 2002 FDA 483 Church & Dwight Co., Inc. - Form 483, 2002-02-14
January, 2001 FDA 483 Avid Medical, Inc. - Form 483, 2001-01-18
March, 2003 FDA 483 Defense Health Clinical Systems - Form 483, 2003-03-13
October, 2003 FDA 483 Bruker BioSpin MRI Gmbh - Form 483, 2003-10-30
July, 2001 FDA 483 PARI Respiratory Equipment, Inc. - Form 483, 2001-07-13
April, 2000 FDA 483 Ashland, Inc. - Form 483, 2000-04-07
December, 2000 FDA 483 Myer, Edwin C MD - Form 483, 2000-12-13
August, 2002 EIR MicroAire Surgical Instruments, LLC - EIR, 2002-08-27
January, 2000 EIR Boehringer Ingelheim Chemicals, Inc. - EIR, 2000-01-07
December, 2011 EIR GEODIS Logistics, LLC - EIR, 2011-12-19
July, 2001 EIR PARI Respiratory Equipment, Inc. - EIR, 2001-07-13
April, 2000 EIR Ashland, Inc. - EIR, 2000-04-07
May, 2000 FDA 483 PARI Respiratory Equipment, Inc. - Form 483, 2000-05-03
January, 2001 FDA 483 Response Avid Medical, Inc. - Form 483R, 2001-02-06

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more